Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ultralife (ULBI) EBITDA (2016 - 2025)

Historic EBITDA for Ultralife (ULBI) over the last 15 years, with Q3 2025 value amounting to -$1.5 million.

  • Ultralife's EBITDA fell 23638.91% to -$1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 8270.36%. This contributed to the annual value of $6.0 million for FY2024, which is 1812.82% down from last year.
  • Latest data reveals that Ultralife reported EBITDA of -$1.5 million as of Q3 2025, which was down 23638.91% from $1.8 million recorded in Q2 2025.
  • Ultralife's EBITDA's 5-year high stood at $3.4 million during Q4 2023, with a 5-year trough of -$1.5 million in Q3 2025.
  • In the last 4 years, Ultralife's EBITDA had a median value of $1.1 million in 2024 and averaged $1.3 million.
  • As far as peak fluctuations go, Ultralife's EBITDA skyrocketed by 188456.38% in 2024, and later plummeted by 23638.91% in 2025.
  • Over the past 4 years, Ultralife's EBITDA (Quarter) stood at $904000.0 in 2021, then skyrocketed by 274.89% to $3.4 million in 2023, then crashed by 121.48% to -$728000.0 in 2024, then crashed by 100.27% to -$1.5 million in 2025.
  • Its EBITDA stands at -$1.5 million for Q3 2025, versus $1.8 million for Q2 2025 and $2.2 million for Q1 2025.